Immune or idiopathic thrombocytopenic purpura (ITP) in childhood: what are the risks and who should be treated?
Open Access
- 30 September 2003
- journal article
- editorial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 143 (3) , 287-289
- https://doi.org/10.1067/s0022-3476(03)00360-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancyBritish Journal of Haematology, 2003
- Acute Immune Thrombocytopenia (ITP) in Childhood: Retrospective and Prospective Survey in GermanySeminars in Thrombosis and Hemostasis, 2001
- Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational studyThe Lancet, 2001
- Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelinesThe Lancet, 1997
- A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpuraThe Journal of Pediatrics, 1993
- Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group.Archives of Disease in Childhood, 1992
- Treatment of Acute Idiopathic Thrombocytopenic Purpura (AITP): Cooperative Italian Study Group ResultsPediatric Hematology and Oncology, 1988
- Treatment of acute idiopathic thrombocytopenic purpuraThe Journal of Pediatrics, 1986
- INTRAVENOUS IMMUNOGLOBULIN VERSUS ORAL CORTICOSTEROIDS IN ACUTE IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1985
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981